ACADL and hepatocellular carcinoma: Although etomoxir treatment significantly inhibited cell proliferation of both control and ACADL re-expressing cells, HCC-LM3/AC and HepG2/AC cells still showed inhibited proliferation and colony formation compared with the control cells (Supplementary Fig. 4).